|
| Gabriele Zoppoli | Institut Jules Bordet Christine Galant, Cliniques Universitaires Saint Luc, University of Leuven Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, European Institute of Oncology Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Wellcome Trust Sanger Institute, The Francis Crick Institute, Washington University School of Medicine, Dana-Farber Cancer Institute, Institut Paoli-Calmettes |
| Gabriele Zoppoli | Institut Jules Bordet Christine Galant, Cliniques Universitaires Saint Luc, University of Leuven Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, European Institute of Oncology Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Wellcome Trust Sanger Institute, The Francis Crick Institute, Washington University School of Medicine, Dana-Farber Cancer Institute, Institut Paoli-Calmettes |
| Gunes Gundem | Institut Jules Bordet Christine Galant, Cliniques Universitaires Saint Luc, University of Leuven Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, European Institute of Oncology Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Wellcome Trust Sanger Institute, The Francis Crick Institute, Washington University School of Medicine, Dana-Farber Cancer Institute, Institut Paoli-Calmettes |
| Peter Van Loo | Institut Jules Bordet Christine Galant, Cliniques Universitaires Saint Luc, University of Leuven Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, European Institute of Oncology Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Wellcome Trust Sanger Institute, The Francis Crick Institute, Washington University School of Medicine, Dana-Farber Cancer Institute, Institut Paoli-Calmettes |
| Diether Lambrechts | Institut Jules Bordet Christine Galant, Cliniques Universitaires Saint Luc, University of Leuven Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, European Institute of Oncology Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Wellcome Trust Sanger Institute, The Francis Crick Institute, Washington University School of Medicine, Dana-Farber Cancer Institute, Institut Paoli-Calmettes |
| Ron Bose | Institut Jules Bordet Christine Galant, Cliniques Universitaires Saint Luc, University of Leuven Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, European Institute of Oncology Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Wellcome Trust Sanger Institute, The Francis Crick Institute, Washington University School of Medicine, Dana-Farber Cancer Institute, Institut Paoli-Calmettes |
| Peter J Campbell | Institut Jules Bordet Christine Galant, Cliniques Universitaires Saint Luc, University of Leuven Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, European Institute of Oncology Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Wellcome Trust Sanger Institute, The Francis Crick Institute, Washington University School of Medicine, Dana-Farber Cancer Institute, Institut Paoli-Calmettes |
| Christos Sotiriou | Institut Jules Bordet Christine Galant, Cliniques Universitaires Saint Luc, University of Leuven Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, European Institute of Oncology Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Wellcome Trust Sanger Institute, The Francis Crick Institute, Washington University School of Medicine, Dana-Farber Cancer Institute, Institut Paoli-Calmettes |